mProX™ Human GRK3 Stable Cell Line
- Product Category:
- Membrane Protein Stable Cell Lines
- Subcategory:
- Kinase Cell Lines
To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Lot Number
Made to Order Inquiry
InquiryProduct Information
Product Properties
Protocols
Please visit our protocols page.
Customer Reviews
Edison
Verified Customer
Pandora
Verified Customer
Any questions about our products? Please visit our frequently asked questions page.
Published Data
Fig.1 GRK3 was up-regulated in human metastatic prostate tumors and associated with elevated angiogenesis.
GRK3 IHC staining of prostatic cancerous and benign tissues. Stronger staining in advanced castration-resistant prostate cancer (C), comparable weak staining in localized prostate cancer (B), stronger staining in benign prostatic hyperplasia and negative luminal cells (A), stronger staining in skeletal metastasis around bone trabeculae (D), and the strongest staining observed in these tissue categories in soft tissue metastasis (E).
Ref: Li, Wenliang, et al. "GRK3 is essential for metastatic cells and promotes prostate tumor progression." Proceedings of the National Academy of Sciences 111.4 (2014): 1521-1526.
Pubmed: 24434559
DOI: 10.1073/pnas.1320638111
Research Highlights
By mediating CREB activation and acting as a new essential activator of NE phenotypes, these findings suggest that GRK3 is a novel factor that promotes NED in prostate cancer cells.
Sang, Meixiang, et al. "GRK3 is a direct target of CREB activation and regulates neuroendocrine differentiation of prostate cancer cells." Oncotarget 7.29 (2016): 45171.
Pubmed:
27191986
DOI:
10.18632/oncotarget.9359
In colon cancer, there was a specific overexpression of GRK3, which may mediate the proliferation of cancer cells, contribute to the disease's development, act as a poor prognostic sign, and could even be a novel target for treatment.
Jiang, Tao, et al. "Overexpression of GRK3, promoting tumor proliferation, is predictive of poor prognosis in colon cancer." Disease Markers 2017 (2017).
Pubmed:
29445249
DOI:
10.1155/2017/1202710